Paul Berg

Paul Berg (June 30, 1926 – February 15, 2023) was an American biochemist renowned for developing recombinant DNA technology, which enabled the creation of hybrid DNA molecules from different organisms. His pioneering work on the biochemistry of nucleic acids, particularly the use of restriction enzymes to join DNA segments, earned him a share of the 1980 Nobel Prize in Chemistry alongside Walter Gilbert and Frederick Sanger. Berg served as a professor of biochemistry at Stanford University, where he conducted much of his research on DNA tumor viruses like SV40 and advanced techniques for gene splicing.

In response to potential biohazards from recombinant DNA experiments, Berg organized the 1975 Asilomar Conference, which established voluntary guidelines for containment and safety in genetic engineering research, influencing global regulatory frameworks. This self-imposed moratorium and subsequent protocols demonstrated his commitment to responsible innovation amid early debates on the technology's risks. Berg's contributions laid foundational groundwork for biotechnology applications, including synthetic insulin and vaccines, while his leadership in ethical oversight shaped the field's development.

Paul Berg was born on June 30, 1926, in Brooklyn, New York, to Harry Bergsaltz (later shortened to Berg) and Sarah Brodsky, both Jewish immigrants from Russia (now part of Belarus, originating from a shtetl near Uman). His parents had no formal education and arrived in the United States during a wave of Eastern European Jewish migration in the early 20th century. Berg's father worked in the garment industry, initially as a furrier producing trim for clothing and later as a clothing manufacturer, reflecting the modest socioeconomic circumstances of many immigrant families in New York's urban working class.